Increased serum levels of hepcidin, the hepatic hormone regulating iron metabolism, have been suggested to contribute to the functional iron deficiency that limit erythropoiesis in CHD[2,3,31]. The gene discussed is HAMP; the disease is Iron deficiency anemia.